Literature DB >> 3011439

Augmentation of human blood monocyte microbicidal activity by RU 41740, a glycoprotein extract from Klebsiella pneumoniae.

H Nielsen.   

Abstract

Non-specific activation of host defences may have a significant impact on the outcome of infections in the immunocompromized patient. RU 41740, a glycoprotein extract from Klebsiella pneumoniae, effective in increasing resistance to experimental infections in animals, has been examined in vitro for its effect on human blood monocyte locomotion, phagocytosis, killing of Candida albicans, and release of superoxide anion. RU 41740 had no chemo-attractant activity nor any effect on monocyte chemotactic and phagocytic function. Candidacidal capacity and superoxide anion production by monocytes were significantly enhanced after preincubation with RU 41740 greater than 1.0 microgram/ml. The effect was dose- and time-dependent and was not influenced by the presence of lymphocytes or their culture supernatants. This suggests a direct interaction with monocytes as the mechanism of action of the extract.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011439     DOI: 10.1007/bf00614204

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Human monocyte chemotaxis in vitro. Influence of in vitro variables in the filter assay.

Authors:  H Nielsen; S Olesen Larsen
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1983-04

2.  Macrophage-stimulating effect of a synthetic muramyl dipeptide and its adjuvant-active and -inactive analogs for the production of T-cell activating monokines.

Authors:  H Iribe; T Koga; K Onoue; S Kotani; S Kusumoto; T Shiba
Journal:  Cell Immunol       Date:  1981-10       Impact factor: 4.868

3.  Effect of Corynebacterium parvum, methanol-extraction residue of BCG, and levamisole on macrophage random migration, chemotaxis, and pinocytosis.

Authors:  N A Sher; D G Poplack; R M Blaese; T M Brown; S D Chaparas
Journal:  J Natl Cancer Inst       Date:  1977-06       Impact factor: 13.506

4.  Monocyte function in man.

Authors:  M C Territo; M J Cline
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

5.  Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.

Authors:  H U Schorlemmer; K Bosslet; H H Sedlacek
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

6.  Stimulation of migration of human monocytes by bacterial cell walls and muramyl peptides.

Authors:  T Ogawa; S Kotani; K Fukuda; Y Tsukamoto; M Mori; S Kusumoto; T Shiba
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

7.  Cytotoxicity of rat macrophages activated by persistent or biodegradable bacterial cell walls.

Authors:  R J Smialowicz; J H Schwab
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

8.  Stimulation of cell-mediated immunity by bestatin correlates with reduction of bacterial persistence in experimental chronic Salmonella typhimurium infection.

Authors:  G Dickneite; F Kaspereit; H H Sedlacek
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

9.  Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.

Authors:  S Sone; I J Fidler
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

10.  Macrophage activation by bacterial cell walls and related synthetic compounds.

Authors:  H Takada; M Tsujimoto; K Kato; S Kotani; S Kusumoto; M Inage; T Shiba; I Yano; S Kawata; K Yokogawa
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.